Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Thomas Rampling & Mark Nelson. (2011) Clinical utility and long-term use of atazanavir in the treatment of HIV-1 infection. Virus Adaptation and Treatment 3, pages 25-34.
Read now
Read now
Articles from other publishers (19)
Faraan O. Rahim, Francis M. Sakita, Lauren Coaxum, Amedeus V. Maro, James S. Ford, Kate Hatter, Kalipa Gedion, Saad M. Ezad, Sophie W. Galson, Gerald S. Bloomfield, Alexander T. Limkakeng, Monica S. Kessy, Blandina Mmbaga & Julian T. Hertz. (2023) Longitudinal ECG changes among adults with HIV in Tanzania: A prospective cohort study. PLOS Global Public Health 3:10, pages e0002525.
Crossref
Crossref
Ganesh Kasinadhuni, Vineela Chikkam, Parminder Singh & Rajesh Vijayvergiya. 2022. COVID-19: Effects in Comorbidities and Special Populations. COVID-19: Effects in Comorbidities and Special Populations
102
136
.
Colin Baigent, Stephan Windecker, Daniele Andreini, Elena Arbelo, Emanuele Barbato, Antonio L Bartorelli, Andreas Baumbach, Elijah R Behr, Sergio Berti, Héctor Bueno, Davide Capodanno, Riccardo Cappato, Alaide Chieffo, Jean Philippe Collet, Thomas Cuisset, Giovanni de Simone, Victoria Delgado, Paul Dendale, Dariusz Dudek, Thor Edvardsen, Arif Elvan, José R González-Juanatey, Mauro Gori, Diederick Grobbee, Tomasz J Guzik, Sigrun Halvorsen, Michael Haude, Hein Heidbuchel, Gerhard Hindricks, Borja Ibanez, Nicole Karam, Hugo Katus, Fredrikus A Klok, Stavros V Konstantinides, Ulf Landmesser, Christophe Leclercq, Sergio Leonardi, Maddalena Lettino, Giancarlo Marenzi, Josepa Mauri, Marco Metra, Nuccia Morici, Christian Mueller, Anna Sonia Petronio, Marija M Polovina, Tatjana Potpara, Fabien Praz, Bernard Prendergast, Eva Prescott, Susanna Price, Piotr Pruszczyk, Oriol Rodríguez-Leor, Marco Roffi, Rafael Romaguera, Stephan Rosenkranz, Andrea Sarkozy, Martijn Scherrenberg, Petar Seferovic, Michele Senni, Francesco R Spera, Giulio Stefanini, Holger Thiele, Daniela Tomasoni, Luccia Torracca, Rhian M Touyz, Arthur A Wilde & Bryan Williams. (2022) ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up. Cardiovascular Research 118:7, pages 1618-1666.
Crossref
Crossref
Colin Baigent, Stephan Windecker, Daniele Andreini, Elena Arbelo, Emanuele Barbato, Antonio L Bartorelli, Andreas Baumbach, Elijah R Behr, Sergio Berti, Héctor Bueno, Davide Capodanno, Riccardo Cappato, Alaide Chieffo, Jean-Philippe Collet, Thomas Cuisset, Giovanni de Simone, Victoria Delgado, Paul Dendale, Dariusz Dudek, Thor Edvardsen, Arif Elvan, José R González-Juanatey, Mauro Gori, Diederick Grobbee, Tomasz J Guzik, Sigrun Halvorsen, Michael Haude, Hein Heidbuchel, Gerhard Hindricks, Borja Ibanez, Nicole Karam, Hugo Katus, Fredrikus A Klok, Stavros V Konstantinides, Ulf Landmesser, Christophe Leclercq, Sergio Leonardi, Maddalena Lettino, Giancarlo Marenzi, Josepa Mauri, Marco Metra, Nuccia Morici, Christian Mueller, Anna Sonia Petronio, Marija M Polovina, Tatjana Potpara, Fabien Praz, Bernard Prendergast, Eva Prescott, Susanna Price, Piotr Pruszczyk, Oriol Rodríguez-Leor, Marco Roffi, Rafael Romaguera, Stephan Rosenkranz, Andrea Sarkozy, Martijn Scherrenberg, Petar Seferovic, Michele Senni, Francesco R Spera, Giulio Stefanini, Holger Thiele, Daniela Tomasoni, Lucia Torracca, Rhian M Touyz, Arthur A Wilde & Bryan Williams. (2022) ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up. European Heart Journal 43:11, pages 1059-1103.
Crossref
Crossref
Hossein Mazaherpour, Masoomeh Sofian, Elham Farahani, Alireza Abdi, Sakine Mazaherpour, Anahita Bavand & Amitis Ramezani. (2022) Comparing Outcomes of Two Antiviral Therapy Combinations among COVID-19 Patients. BioMed Research International 2022, pages 1-7.
Crossref
Crossref
Kristen Bova Campbell. 2022. Torsades de Pointes. Torsades de Pointes
231
266
.
Nicolás R. Robles, Francesco Fici, Julian Valladares & Guido Grassi. (2021) Antiretroviral Treatment and Antihypertensive Therapy. Current Pharmaceutical Design 27:40, pages 4116-4124.
Crossref
Crossref
Shubham Agarwal & Sanjeev Kumar Agarwal. (2020) Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications. Cardiovascular Drugs and Therapy 35:3, pages 427-440.
Crossref
Crossref
Audrey Fresse, Delphine Viard, Serena Romani, Alexandre Gérard, Marion Lepelley, Fanny Rocher, Joe-Elie Salem & Milou-Daniel Drici. (2021) Spontaneous reported cardiotoxicity induced by lopinavir/ritonavir in COVID-19. An alleged past-resolved problem. International Journal of Cardiology 324, pages 255-260.
Crossref
Crossref
Denio A. Ridjab, Ignatius Ivan, Fanny Budiman & Dwi Jani Juliawati. (2021) Current evidence for the risk of PR prolongation, QRS widening, QT prolongation, from lopinavir, ritonavir, atazanavir, and saquinavir. Medicine 100:31, pages e26787.
Crossref
Crossref
Vincenzo Russo, Roberta Bottino, Andreina Carbone, Anna Rago, Andrea Antonio Papa, Paolo Golino & Gerardo Nigro. (2020) COVID-19 and Heart: From Clinical Features to Pharmacological Implications. Journal of Clinical Medicine 9:6, pages 1944.
Crossref
Crossref
Zhenisgul Tlegenova, Bekbolat Zholdin, Meirambek Kurmangazin, Bulat Khamidulla & Zhambul Zhailybaev. (2020) Severe bradyarrhythmia requiring temporary pacemaker in a COVID-19 patient receiving lopinavir/ritonavir treatment: a case report. Heart, Vessels and Transplantation 4:Issue 2, pages 79.
Crossref
Crossref
Shailesh Singh & Katyayni Singh. (2020) Arrhythmia in people living with HIV/AIDS. Nigerian Journal of Cardiology 17:1, pages 1.
Crossref
Crossref
Daniel B Chastain, Michael P Veve & Jamie L Wagner. (2018) Abnormal QTc Syndrome in HIV-Infected Patients: A Systematic review of Prevalence and Risk Factors. Antiviral Therapy 24:6, pages 459-465.
Crossref
Crossref
D. Leoni & J. Rello. (2017) Cardiac arrest among patients with infections: causes, clinical practice and research implications. Clinical Microbiology and Infection 23:10, pages 730-735.
Crossref
Crossref
Kathleen M.S.E. Reyskens & M. Faadiel Essop. (2014) HIV protease inhibitors and onset of cardiovascular diseases: A central role for oxidative stress and dysregulation of the ubiquitin–proteasome system. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1842:2, pages 256-268.
Crossref
Crossref
Balaji Yegneswaran, John B. Kostis & C.S. Pitchumoni. (2011) Cardiovascular manifestations of acute pancreatitis. Journal of Critical Care 26:2, pages 225.e11-225.e18.
Crossref
Crossref
Elsayed Z Soliman, Jens D Lundgren, Mollie P Roediger, Daniel A Duprez, Zelalem Temesgen, Markus Bickel, Judith C Shlay, Charurut Somboonwit, Peter Reiss, James H Stein & James D Neaton. (2011) Boosted protease inhibitors and the electrocardiographic measures of QT and PR durations. AIDS 25:3, pages 367-377.
Crossref
Crossref
. (2010) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 19:6, pages i-xiii.
Crossref
Crossref